Posts Tagged ‘Dr. Jeff McQuaite’

Chiropractic and pain relief

Dr. Jeff McQuaite, a Doylestown Chiropractor, has found a new study demonstrating chiropractic’s effectiveness in relieving pain.  This new study added more information to the way we understand how chiropractic adjustments help the brain with pain relief.  The New Zealand College of Chiropractic study focused on people with a history of reoccurring neck stiffness and/or neck pain but showed no acute symptoms at the time of the study.  The subjects were hooked up to computers that read brainwaves, and were given chiropractic adjustments. When they were adjusted, the computers showed that parts of the brain where pain and suffering occurs had less activity.   These findings may help to explain the mechanisms responsible for the effective relief of pain and restoration of functional ability documented after spinal manipulation treatment.


Stress, Tax Season & Massage!

What are the health consequences of the tax season burden on American taxpayers?
by Mike Adams, the Health Ranger, NaturalNews Editor, Dr. Jeff McQuaite, Doylestown Chiropractor

It’s tax season in the U.S. again, and when it comes to discussions about the financial burden on the economy from the complexity of the current U.S. tax code, most of the criticisms focus on the number of dollars (or hours) spent in compliance. According to a study from the Tax Foundation, U.S. taxpayers spend over 6 billion hours and over $256 billion working to comply with the current tax code. That’s a lot of dollars and hours, but it may pale in comparison to yet another cost: The health consequences of the stress caused by the U.S. tax code.
Preparing your taxes is stressful for lots of reasons. First, there’s just the time and frustration in trying to track down receipts, fill out the forms and even translate IRS instructions into plain English. Nobody in their right mind enjoys this job, and it takes a toll on human physiology. Stress causes immune suppression, for one thing. Adrenal depletion can result in hormonal disorders, sleep disorders and even an increased risk of heart attacks.
But that’s just the beginning of the story. The greater cost in tax code compliance may come from the fear factor.
The U.S. tax code, you see, is enforced in large part by fear: Fear of an audit, fear of arrest, fear of making an honest mistake that gets you into trouble. Even when you make a full-on attempt to prepare your taxes as honestly and accurately as you can, it’s a well-known fact that no two accountants will ever arrive at the same dollar figure that you owe. So how can there be a “right” answer on your taxes? And if nobody is right, then everybody must be wrong… right? And being wrong can get you into trouble. So this fear of making a mistake takes another huge toll on your physiology.
Taxes are taxing to your health, too.
To my knowledge, no one has made any scientific attempt to calculate the health costs of tax code compliance. But it’s not difficult to imagine that the additional stress and fear that is placed upon every American by the IRS must have some sort of measurable cost in terms of additional health care expenses. Those health care expenses, ironically, are often paid for by taxpayers.
So we are paying for ourselves to be stressed out and then possibly end up in the hospital where we cover each other’s health care costs by paying the very taxes that stressed us out in the first place.
What’s wrong with this picture?
But now for some good news! You may very well have been getting a tax-deductible massage and did not know it. Yes, that’s correct! Your massage therapy may very well be tax deductible.

Many deductions, such as medical expenses, require you to overcome a minimum. For example, only medical expenses that exceed 7.5% of your adjusted gross income are allowed. This means an individual with an adjusted gross income of $40,000 can only deduct medical expenses above and beyond $3,000.
Your medical care expenses typically include medical insurance, some Medicare costs, and miscellaneous costs of health care. These could include costs for making alterations to your home prescribed for your medical condition, removing toxic substances from your home, enrolling in weight-loss programs, dental work, and travel-related expenses to get to your medical care, including mileage expense. Even that massage you got to relieve stress MAY be deductible. Other potentially deductible expenses include prostheses, and ointments or lotions for wound and skin care.
Deductible medical services can be performed by someone other than your doctor. If you have a condition like a bad back and your doctor says you need regular massage, this treatment is deductible. Make sure you get a prescription for massage from your doctor saying you need these services.
Remember that the cost of the massage therapy is TAX DEDUCTIBLE as long as a physician prescribes it.
If you routinely get massage to help manage stress, blood circulation, chronic pain, or other medical conditions ask your doctor for a prescription and get a receipt for each massage from your massage therapist.

Doylestown Chiropractor, Botox for headaches?!?

FDA Approves Botox for Elbow Spasms. Are Migraines Next?
03/10/10 Company News, Healthcare

The Food and Drug Administration on Tuesday approved Allergan’s (AGN) wrinkle-smoothing drug Botox to treat elbow, wrist and finger spasms. Spasticity in the flexor muscles, common after stroke, traumatic brain injury or the progression of multiple sclerosis, afflicts 1 million Americans, many in their upper limbs, according to Allergan, based in Irvine, Calif. (Botox does not affect darkened elbow skin and folds.)

“Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living, and may affect how a patient looks,” says Dr. Russell Katz, director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. Botox, injected into the affected muscles, blocks the connections between nerves and muscles, paralyzing the spastic muscle for an average of up to three months in clinical trials.

Sweating, Spasm…and Migraines?

Because the active ingredient in Botox is the highly poisonous botulinum toxin, the FDA last year required Allergan to warn that the effect of Botox could spread from the area of injection to other areas of the body, causing symptoms similar to those of botulism, including potentially life-threatening difficulty with swallowing and breathing.

The FDA further stressed that Botox has not been proved a safe, effective treatment for larger muscles such as those in the legs and others in the upper limbs. Nor is it safe for treatment of fixed contracture, a condition that affects range of motion. The most common adverse reactions were nausea, fatigue, bronchitis, muscle weakness and pain in the arms.

Although better known for its cosmetic applications, Botox is approved to treat such therapeutic conditions as underarm sweating, neck spasms, and eye-muscle disorders. Therapeutic sales of Botox accounted for approximately 52% of Allergan sales last year and increased about 4% over 2008. Cosmetic sales accounted for approximately 48% and decreased approximately 4%. Allergan is testing Botox for other medical uses, including migraines, which may be the most significant area for the drug’s future sales growth.

‘Off-Label’ Treatments

While Botox’s FDA-approved uses may be limited, doctors are allowed to prescribe it in unapproved (“off-label”) treatments for muscle spasms. But pharmaceutical companies are prohibited from promoting off-label uses. Last year, Eli Lilly (LLY) paid a $1.42 billion fine, and Pfizer (PFE) paid a record $2.3 billion fine, to settle charges of off-label promotions.

Allergan has sued the FDA, arguing that these rules violate its First Amendment right to free speech. It wants to be allowed to “share relevant information with the medical community on the safe use” of Botox for off-label uses. Tuesday’s approval, demonstrating that the FDA doesn’t hold a grudge, eases investors’ concerns on that front. Botox sales rose 5.6% last quarter, to $347.7 million, and Allergan forecasts full-year 2010 net sales of $1.33 billion to $1.37 billion. Allergan shares rose some 1.8% in morning trading.

While therapeutic uses may continue to fuel increases, cosmetic uses may too: Despite the recession, plastic surgeries declined only 2% in 2009 — nearly 10 million procedures in the U.S. included 2.5 million procedures involving botulinum toxin type A (whether Botox or rival Ipsen Group’s Tercica’s Dysport).